Journal
CEPHALALGIA
Volume 31, Issue 5, Pages 520-529Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0333102410383590
Keywords
Chronic migraine; definition; classification; epidemiology
Categories
Funding
- German Federal Ministry for Education and Research
- Allergan, Inc.
- Irvine, CA, USA
- Allergan
- Bayer
- German Research Council (DFG)
- German Ministry of Education and Research (BMBF)
- European Union
- Almirall
- AstraZeneca
- GlaxoSmithKline
- Janssen-Cilag
- Pfizer
Ask authors/readers for more resources
Objective: The objective of our study was to field test different chronic migraine (CM) criteria and compare CM epidemiological profiles, which include demographic, personal, and lifestyle characteristics, with high-frequency episodic migraine (HFEM) and low-frequency episodic migraine (LFEM). Methods: Questionnaires were mailed to a random sample of 18,000 18-65-year-olds in demographically diverse regions of Germany. The epidemiological data for the three classifications of CM, LFEM and HFEM were assessed using descriptive statistics, Pearson Chi-square, and analysis of variance tests. Results: Among 9350 respondents, CM_I was the most restrictive (N=37, 0.4%), followed by CM_II (N=45, 0.5%) and CM_III (N=185, 2.0%). CM groups did not differ in distribution by age, gender, body mass index, education or smoking and alcohol consumption. Compared to those with LFEM and HFEM, those with CM (CM_III) had significantly different epidemiological profiles. Conclusions: CM prevalence varies by case definition. The epidemiological profiles of the three CM groups are similar but differ significantly from those of HFEM and LFEM. Optimal definitions for clinical practice and epidemiological research require additional field testing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available